Next-Generation Antibody-Drug Conjugates (ADCs) for Cancer Therapy

ACS Medicinal Chemistry Letters

Volumn 7, Issue 11, 2016, Pages 972-973

  Junutula, Jagath Reddy ^a   Gerber, Hans Peter ^b  

^a Cellerant Therapeutics Inc   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; DRUG ANTIBODY;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL ACTIVATION; CELL DEATH; CELL MATURATION; DENDRITIC CELL; DRUG CONJUGATION; EDITORIAL; HEALTH CARE QUALITY; HUMAN; IMMUNOGENICITY; ONCOLOGY; PRIORITY JOURNAL; SOLID TUMOR; TUMOR IMMUNITY;

EID: 84994834770     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.6b00421     Document Type: Editorial

References (9)

1. Sievers, E. L.; Senter, P. D. Antibody-Drug Conjugates in Cancer Therapy Annu. Rev. Med. 2013, 64, 15-29 10.1146/annurev-med-050311-201823
2. Gerber, H. P.; Koehn, F. E.; Abraham, R. T. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics Nat. Prod. Rep. 2013, 30, 625-639 10.1039/c3np20113a
3. Donaghy, H. Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates mAbs 2016, 8, 659-671 10.1080/19420862.2016.1156829
4. https://clinicaltrials.gov.
5. Junutula, J. R.; Raab, H.; Clark, S.; Bhakta, S.; Leipold, D. D.; Weir, S.; Chen, Y.; Simpson, M.; Tsai, S. P.; Dennis, M. S.; Lu, Y.; Meng, Y. G.; Ng, C.; Yang, J.; Lee, C. C.; Duenas, E.; Gorrell, J.; Katta, V.; Kim, A.; McDorman, K.; Flagella, K.; Ross, S.; Venook, R.; Spencer, S. D.; Wong, W. L.; Lowman, H. B.; Vandlen, R.; Slikowski, M. X.; Scheller, R. H.; Polakis, P.; Malllet, W. Site-specific conjugation of cytotoxic drugs to antibodies substantially improves the therapeutic index Nat. Biotechnol. 2008, 26, 925-932 10.1038/nbt.1480
6. Panowski, S.; Bhakta, S.; Raab, H.; Polakis, P.; Junutula, J. R. Site-specific antibody drug conjugates for cancer therapy mAbs 2014, 6, 34-45 10.4161/mabs.27022
7. Agarwal, P.; Bertozzi, C. R. Site-Specific Antibody-Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development Bioconjugate Chem. 2015, 26, 176-192 10.1021/bc5004982
8. Harris, S. J.; Brown, J.; Lopez, J.; Yap, T. A. Immuno-oncology combinations: raising the tail of the survival curve Cancer Biol. Med. 2016, 13, 171-193 10.20892/j.issn.2095-3941.2016.0015
9. Gerber, H.; Sapra, P.; Loganzo, F.; May, C. Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect? Biochem. Pharmacol. 2016, 102, 1-6 10.1016/j.bcp.2015.12.008